Health
Oxford vaccine stimulates broad antibody and T cell functions – Medical Xpress
Today, researchers from the University of Oxford have published further data from the Phase I/II clinical trials of the ChAdOx1 nCoV-19 coronavirus vaccine, evidencing…
Today, researchers from the University of Oxford have published further data from the Phase I/II clinical trials of the ChAdOx1 nCoV-19 coronavirus vaccine, evidencing the decision to move to a two-dose regimen in ongoing phase III trials, and how ChAdOx1 nCov-19 induces broad antibody and T cell functions.
These findings are reported in two papers, both released in the peer-reviewed journal Nature Medicine.
Previous studies have shown that in order to develop any vaccine against SARS-CoV-2 coronavirus,…
-
Noosa News21 hours agoBrisbane council budget 2025: Winners and losers
-
Business16 hours ago3 of the best ASX stocks to buy now with $2,500
-
Noosa News16 hours agoBrisbane’s 2025–26 budget revealed: rate hikes, service fee rises and major infrastructure plans
-
Noosa News15 hours agoRapist who tortured woman for weeks claims he deserves a lighter sentence for not letting her die